Skip to main content
. 2016 Jun 23;115(2):236–242. doi: 10.1038/bjc.2016.169

Table 2. The number of patients within the prostate cancer cohort that were dichotomously categorised for each biomarker.

Biomarker (score) Number of cancer patients scored Number positive (%) Number negative (%)
Ki67 (>110) 161 11 (6.8) 150 (93.2)
DLX2 (>10) 185 135 (73) 50 (27)